Skip Navigation LinksHome > March 2014 - Volume 57 - Issue 1 > Ethical Dimensions of First-trimester Fetal Aneuploidy Scree...
Clinical Obstetrics & Gynecology:
doi: 10.1097/GRF.0000000000000014
Noninvasive Screening for Fetal Aneuploidies: Eliminating Unwanted Surprises

Ethical Dimensions of First-trimester Fetal Aneuploidy Screening

CHERVENAK, FRANK A. MD*; McCULLOUGH, LAURENCE B. PhD

Collapse Box

Abstract

Noninvasive first-trimester fetal aneuploidy screening provides pregnant women with risk assessment information early in pregnancy. Noninvasive first-trimester aneuploidy screening includes imaging of the fetus and maternal serum analyte and assessment of fetal genetic material in the maternal circulation. The ethical challenges of noninvasive first-trimester fetal aneuploidy screening concern the physician’s role in the informed consent process for risk assessment, the goal of which is to empower pregnant women to make informed decisions about noninvasive aneuploidy screening. This article provides physicians with an ethical framework for the professionally responsible management of these ethical challenges and for those related to emerging technologies.

© 2014, Lippincott Williams & Wilkins

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.